DNA

Network Biosystems, Inc. is the leading provider of the full set of technologies and products for the emerging field of Rapid DNA Analysis (RDA). RDA enables the identification (by fragment sizing or nucleic acid sequencing) of the most informative subset of a given human or pathogen genome, allowing end users to make decisions in real time.

JEOL develops instruments used to advance scientific research and technology. JEOL has expertise in the field of electron microscopy, mass spectrometry and NMR spectrometry, and e-beam lithography leadership.

ExQor's patented bio-nanotransport platform enables delivery of many different types of drugs throughout the body, including the brain. Uniquely and unlike almost all other nano-particles, ExQor's could also become a powerful new therapeutic in its own right.

ExQor's multiple patents cover Clathrin, a vitally essential protein responsible for transporting a very broad variety of substances—from cholesterol to neurotransmitters—to the interior of cells. Clathrin is also implicated in viral diseases, like HIV.

Ensemble Discovery is developing a new class of therapeutics - the Ensemblins™, orally bioavailable small molecule macrocyclic compounds that have the potential to behave like biologics and can disrupt protein-protein interactions. We have two complementary platforms that provide access to these molecules. Firstly, we use our proprietary DNA-Programmed Chemistry™ (DPC™) platform to generate hundreds of thousands of these molecules for rapid screening. Secondly, we have highly developed methods for the synthesis of Ensemblins as discrete molecules using conventional chemistry.

BioTrove, Inc. provides micro and nano-scale technology platforms for life science and drug discovery research applications.